The world of sequence variation IP is complicated and confusing, and fraught with legal risk, but there is a solution, as Ellen Sherin of GQ Life Sciences reports. The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021, up from $172.5 billion in 2016, rising at a compound annual growth…
We are again excited to welcome thought leader Dr. Stephen Tedeschi as a guest blogger. Dr. Tedeschi, is a Partner at PatentVantage, a leading patent research and strategy firm. He is also an Adjunct Faculty member at the National Institute of Health’s Foundation for Advanced Education in the Sciences (FAES). For more on Dr. Tedeschi,…
We are excited to welcome thought leader Dr. Stephen Tedeschi as a guest blogger. Dr. Tedeschi, is a Partner at PatentVantage, a leading patent research and strategy firm. He is also an Adjunct Faculty member at the National Institute of Health’s Foundation for Advanced Education in the Sciences (FAES). For more on Dr. Tedeschi, please…
About a week ago, the FTC filed a suit against Endo Pharmaceuticals (among others) for blocking generic competition of its Opana ER and Lidoderm products. It is alleging that in addition to paying to delay competitive products, Endo used a no-AG commitment that gave Watson Laboratories more than 7 months of their own monopoly on…
I’m going to let you in on a little secret: there’s a reason why we are the market leader in patent sequence search. It has surprisingly little to do with our user-friendly search interface, our stellar customer support, or our good looks. While (at least some of) these things certainly help, it is the content…
As more and more researchers and IP specialists sign up to use LifeQuest (full-text life science patent search tool), we have been receiving an increasing amount of positive feedback. This made us all feel so good that to say thanks, our team was inspired to create the LifeQuest Search Bar, a free tool that lets…
When you work with DNA or protein sequences, inevitably, you’re going to run into the challenge of finding similar biological sequences that have been listed in patents. In most cases, you’re likely to know specific mutations at specific positions that you want to search for. The challenge is, how do you define a query that…
Because GenomeQuest’s GQ-Pat is a document database rather than a family database, you might hit the same sequence more than once because it occurs in document A and document B both in the same family. That’s actually incredibly useful because it allows you to examine how sequences found in patents change from patent family member…
Each year, pharmaceuticals, biotech organizations, academic institutions and law firms commit costly errors that happen due to poorly informed IP portfolio decisions. Relating to biological sequence search, here are nine serious mistakes we hate to see life science companies make.
NCBI BLAST is the most popular sequence comparison algorithm, but it was not built with intellectual property sequence search in mind. Here we discuss three problems with using NCBI BLAST alone for such sequence alignments.